Abstract:Kawasaki disease is a pressing acute self-limiting inflammatory disorder disease which lack of specific biomarkers. Our research aims to investigate the serum expression of a novel immune regulator PK2 in children with Kawasaki disease and to evaluate the ability of PK2 to predict Kawasaki disease. A total of 70 children with Kawasaki disease in the Children's Hospital of Chongqing Medical University who were first diagnosed, 20 children with common fever admitted to hospital due to bacterial infection during the same period, and 31 children underwent physical examination were included in this study. Venous blood was collected for complete blood count, CRP, ESR, PCT, and PK2 before clinical intervention. The predictive potential of PK2 as a biomarker for the diagnosis of Kawasaki disease was judged by correlation analysis, the receiver operating characteristic (ROC) and combined score. Compared with healthy children and children with common fever, children diagnosed with Kawasaki disease had significantly lower serum PK2 concentrations (median 28,503.7208 ng/ml, 26,242.5484 ng/ml, and 16,890.2452 ng/ml, respectively, Kruskal–Wallis test: p < 0.0001). Analysis of the existing indicators in other laboratories showed that WBC (Kruskal–Wallis test: p < 0.0001), PLT (Kruskal–Wallis test: p = 0.0018), CRP (Mann–Whitney U: p < 0.0001), ESR (Mann–Whitney U: p = 0.0092), NLR (Kruskal–Wallis test: p < 0.0001), and other indicators were significantly increased compared with healthy children and children with common fever, RBC (Kruskal–Wallis test: p < 0.0001), and Hg (Kruskal–Wallis test: p < 0.0001) were significantly decreased in children with Kawasaki disease conversely. In the analysis of the Spearman correlation, it was found that serum PK2 concentration and NLR ratio were significantly negatively correlated in children with Kawasaki disease (r s = -0.2613, p = 0.0301). In the analysis of the ROC curves, it was found that the area under the PK2 curve was 0.782 (95% confidence interval 0.683–0.862; p < 0.0001), the ESR was 0.697 (95% confidence interval 0.582–0.796; p = 0.0120), the CRP was 0.601 (95% confidence interval 0.683–0.862; p = 0.1805), and the NLR was 0.735 (95% confidence interval 0.631–0.823; p = 0.0026). PK2 can significantly predict Kawasaki disease independently of CRP and ESR ( p < 0.0001). The combined score of PK2 and ESR can significantly improve the diagnostic performance of PK2 (AUC = 0.827, 95% CI 0.724–0.903, p < 0.0001). The sensitivity was 87.50%, the sensitivity was 75.81%, the positive likelihood ratio was 6.0648, and the Youden index was 0.6331. PK2 has the potential to be a biomarker for early diagnosis of Kawasaki disease, and the combined use of ESR can further improve its diagnostic performance. Our study identifies PK2 as an important biomarker for Kawasaki disease and provides a potential new diagnostic strategy for Kawasaki disease.

Plasma Cyclooxygenase-2 as a Potential Biomarker for Early Diagnosis of Kawasaki Disease

Serum indoleamine 2,3 dioxygenase in children with Kawasaki disease

The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease.

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease

Changes in CD_(69),CD_(25) and HLA-DR Expressions in Peripheral Blood T Cells in Kawasaki Disease

Prokineticin 2 as a potential biomarker for the diagnosis of Kawasaki disease

Serum IL-17A, IL-18, and SCD25 (IL-2R) in Early Diagnosis of Kawasaki Disease

A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.

Prediction of Immune Infiltration Diagnostic Gene Biomarkers in Kawasaki Disease

Evaluation Of Intravenous Immunoglobulin Resistance And Coronary Artery Lesions In Relation To Th1/Th2 Cytokine Profiles In Patients With Kawasaki Disease

Profile of Urinary Cytokines in Kawasaki Disease: Non-Invasive Markers

CXCL10/IP-10 Is a Biomarker and Mediator for Kawasaki Disease

Plasma interleukin-41 serves as a potential diagnostic biomarker for Kawasaki disease

The changes of coagulation profiles in Kawasaki disease and its associations with clinical classification, intravenous immunoglobulin responsiveness and coronary artery involvement

Monitoring of the Serum Proteome in Kawasaki Disease Patients Before and after Immunoglobulin Therapy

Serum levels of angiotensin-converting enzyme 2 in children with Kawasaki disease

Predictive Role of IL-2R and IL-10 in the Anti-inflammatory Response and Antiplatelet Therapy of Kawasaki Disease: A Retrospective Study.

Identification of hub biomarkers and immune-related pathways participating in the progression of Kawasaki disease by integrated bioinformatics analysis

Serum levels of PDGF-CC as a potential biomarker for the diagnosis of Kawasaki disease

Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm

Predictive value of coagulation profiles for Kawasaki disease shock syndrome: a prospective cohort study